Full Length Research Paper
References
|
Al-Akwa AA, Shaher M, Al-Akwa S, Aleryani SL (2009). Free radicals are present in human serum of Catha edulis Forsk (Khat) abusers. J. Ethnopharmacol.125(3):471-473. crossref |
||||
|
Aleryani SL, Aleryani RA, Al-Akwa AA (2011). Khat a drug of abuse: roles of free radicals and antioxidants. Drug Test Anal. 3(9):548-551. crossref |
||||
| Al-Hashem FH, Bin-Jaliah I, Dallak MA, Nwoye LO, Al-Khateeb M, Sakr HF, Eid RA, Al-Gelban KS, Al-Amri HS, Adly MA (2011). Khat (Catha edulis) Extract Increases Oxidative Stress Parameters and Impairs Renal and Hepatic Functions in Rats. Bahrain Med. Bull. 33(1):1-9. | ||||
|
Al-Hashem FH, Dallak MA, Nwoye LO, Bin-Jaliah IM, Al-Amri HS, Rezk MH, Sakr HF, Shatoor AS, Al-Khateeb M (2012). Acute exposure to Catha edulis depresses contractility and induces myocardial infarction in spontaneously contracting, isolated rabbit's heart. Saudi J. Biol. Sci. 19(1):93-101. crossref |
||||
|
Atlabachew M, Torto N, Chandravanshi BS, Redi M (2013). Matrix solid phase dispersion for the HPLC-DAD determination of psychoactive phenylpropylamino alkaloids from khat (Catha edulis Forsk) chewing leaves. Chromatographia 76:401-408. crossref |
||||
|
Becker BF (1993). Towards the physiological function of uric acid. Free Radic. Biol. Med. 14(6):615-631. crossref |
||||
|
Bos MJ, Koudstaal PJ, Hofman A, Witteman JC, Breteler MM (2006). Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke 37(6):1503-1507. crossref |
||||
|
Brenneisen R (1984). [Psychotropic drugs. II. Determination of cannabinoids in Cannabis sativa L. and in cannabis products with high pressure liquid chromatography (HPLC)]. Pharm. Acta Helv. 59(9-10):247-259. PMid:6483924 |
||||
|
Brenneisen R, Fisch HU, Koelbing U, Geisshüsler S, Kalix P (1990). Amphetamine-like effects in humans of the khat alkaloid cathinone. Br. J. Clin. Pharmacol. 30(6):825-828. crossref |
||||
|
Chapman MH, Kajihara M, Borges G, O'Beirne J, Patch D, Dhillon AP, Crozier A, Morgan MY (2010). Severe, acute liver injury and khat leaves. New Eng. J. Med. 362(17):1642-1644. crossref |
||||
|
Choi HK, Mount DB, Reginato AM (2005). American College of Physicians; American Physiological Society. Pathogenesis of gout. Ann. Intern. Med. 143(7):499-516. crossref |
||||
|
Davidson C, Gow AJ, Lee TH, Ellinwood EH (2001). Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res. Rev. 36:1–22. crossref |
||||
|
de Lau LM, Koudstaal PJ, Hofman A, Breteler MM (2005). Serum uric acid levels and the risk of Parkinson disease. Ann. Neurol. 58(5):797-800. crossref |
||||
|
Domenicotti C, Paola D, Vitali A, Nitti M, d'Abramo C, Cottalasso D, Maloberti G, Biasi F, Poli G, Chiarpotto E, Marinari UM, Pronzato MA (2000). Glutathione depletion induces apoptosis of rat hepatocytes through activation of protein kinase C novel isoforms and dependent increase in AP-1 nuclear binding. Free Radic. Biol. Med. 29(12):1280-1290. crossref |
||||
|
Du Y, Chen CP, Tseng CY, Eisenberg Y, Firestein BL (2007). Astroglia-mediated effects of uric acid to protect spinal cord neurons from glutamate toxicity. Glia 55(5):463-472. crossref |
||||
|
Feyissa AM, Kelly JP (2008). A review of the neuropharmacological properties of khat. Prog Neuro-Psychopharmacol. Biol. Psychiatry 32(5):1147-1166. crossref |
||||
|
Guerreiro S, Ponceau A, Toulorge D, Martin E, Alvarez-Fischer D, Hirsch EC, Michel PP (2009). Protection of midbrain dopaminergic neurons by the end-product of purine metabolism uric acid: potentiation by low-level depolarization. J. Neurochem. 109(4):1118-1128. crossref |
||||
|
Hayden MR, Tyagi SC (2004). Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Nutr Metab (Lond), 1(1):10. crossref |
||||
| Hoffman BB, Lefkowitz RJ (1996). Goodman and Gillman's, the pharmacological basis of therapeutics. McGraw-Hill international edition. | ||||
|
Kalix P (1990). Pharmacological properties of the stimulant khat. Pharmacol. Ther. 48(3):397-416. crossref |
||||
|
Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, Truong L, Harris R, Johnson RJ (2002). A role for uric acid in the progression of renal disease. J. Am. Soc. Nephrol. 13(12):2888-2897. crossref |
||||
|
Kelly JP (2011). Cathinone derivatives: a review of their chemistry, pharmacology and toxicology. Drug Test Anal. 3(7-8): 439-453. crossref |
||||
|
Kimani ST, Nyongesa AW (2008). Effects of single daily khat (Catha edulis) extract on spatial learning and memory in CBA mice. Behav. Brain Res. 195(1):192-197. crossref |
||||
|
Klein A, Metaal P (2010). A good chew or good riddance-how to move forward in the regulation of khat consumption. J. Ethnopharmacol. 132(3):584-589. crossref |
||||
|
Kobayashi S, Endou M, Sakuraya F, Matsuda N, Zhang XH, Azuma M, Echigo N, Kemmotsu O, Hattori Y, Gando S (2003). The sympathomimetic actions of l-ephedrine and d-pseudoephedrine: direct receptor activation or norepinephrine release? Anesth. Analg. 97(5):1239-1245. crossref |
||||
|
Lee SC, Liu W, Dickson DW, Brosnan CF, Berman JW (1993). Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J. Immunol. 150(7):2659-2667. PMid:8454848 |
||||
|
Liu B, Gao H, Hong J (2003). Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation. Environ. Health Perspect. 111:1065–1073. crossref |
||||
|
Lukandu OM, Costea DE, Neppelberg E, Johannessen AC, Vintermyr OK (2008). Khat (Catha edulis) induces reactive oxygen species and apoptosis in normal human oral keratinocytes and fibroblasts. Toxicol. Sci. 103(2):311-324. crossref |
||||
| Masoud AM, Al-Shehari BA, Al-Hattar LN, Altaezzi MA, Al-khadher WA, Zindal YN (2012). Alterations in Antioxidant Defense System in the Plasma of Female Khat Chewers of Thamar City, Yemen. Jordan J. Biological Sci. 5(2):129-133 | ||||
|
Mohammed A, Engidawork E (2011). Reproductive parameters are differentially altered following subchronic administration of Catha edulis F. (Khat) extract and cathinone in male rats. J. Ethnopharmacol. 134(3):977-83. crossref |
||||
|
Odenwald M, Warfa N, Bhui K, Elbert T (2010). The stimulant khat--another door in the wall? A call for overcoming the barriers. J. Ethnopharmacol. 132(3):615-619. crossref |
||||
|
Patel HC, Ross FM, Heenan LE, Davies RE, Rothwell NJ, Allan SM (2006). Neurodegenerative actions of interleukin-1 in the rat brain are mediated through increases in seizure activity. J. Neurosci. Res. 83:385–391. crossref |
||||
|
Patel NB (2000). Mechanism of action of cathinone: the active ingredient of khat (Catha edulis). East Afr. Med. J. 77(6):329-332. PMid:12858935 |
||||
|
Pilla R, Held HE, Landon CS, Dean JB (2013). High doses of pseudoephedrine hydrochloride accelerate onset of CNS oxygen toxicity seizures in unanesthetized rats. Neuroscience 246:391-396. crossref |
||||
|
Reagan-Shaw S, Nihal M, Ahmed N (2008). Dose translation from animal to human studies revisited. FASEB J. 22:659–661. crossref |
||||
|
Ringheim GE, Burgher KL, Heroux JA (1995). Interleukin-6 mRNA expression by cortical neurons in culture: evidence for neuronal sources of interleukin-6 production in the brain. J. Neuroimmunol. 63(2):113-123. crossref |
||||
|
Samios VN, Inoue T (2014) Interleukin-1β and interleukin-6 affect electrophysiological properties of thalamic relay cells. Neurosci. Res. doi: 10.1016/j.neures.2014.06.011. [Epub ahead of print] crossref |
||||
|
Shin JA, Park EM, Choi JS, Seo SM, Kang JL, Lee KE, Cho S (2009). Ischemic preconditioning-induced neuroprotection is associated with differential expression of IL-1beta and IL-1 receptor antagonist in the ischemic cortex. J. Neuroimmunol. 217:14-19. crossref |
||||
|
Simmler LD, Buser TA, Donzelli M, Schramm Y, Dieu LH, Huwyler J, Chaboz S, Hoener MC, Liechti ME (2013). Pharmacological characterization of designer cathinones in vitro. Br. J. Pharmacol. 168(2):458-470. crossref |
||||
|
Song C, Horrobin DF, Leonard BE (2006). The comparison of changes in behavior, neurochemistry, endocrine, and immune functions after different routes, doses and durations of administrations of IL-1beta in rats. Pharmacopsychiatry 39(3):88-99. crossref |
||||
|
Strazzullo P, Puig JG (2007). Uric acid and oxidative stress: relative impact on cardiovascular risk?. Nutr. Metab. Cardiovasc Dis. 17(6):409-414. crossref |
||||
|
Tuttolomondo A, Di Raimondo D, di Sciacca R, Pinto A, Licata G (2008). Inflammatory cytokines in acute ischemic stroke. Curr. Pharm. Des. 14:3574–3589. crossref |
||||
|
Yao JK, Dougherty GG, Reddy RD, Matson WR, Kaddurah-Daouk R, Keshavan MS (2013). Associations between purine metabolites and monoamine neurotransmitters in first-episode psychosis. Front Cell Neurosci. 7:90. crossref |
||||
|
Zhang X, Dong F, Mayer GE, Bruch DC, Ren J, Culver B (2007). Selective inhibition of cyclooxygenase-2 exacerbates methamphetamine-induced dopamine depletion in the striatum in rats. J. Neurosci. 150:950-958. crossref |
||||
|
Zhu JP, Xu W, Angulo JA (2006). Methamphetamine – induced cell death : selective vulnerability in neuronal subpopulations of the striatum in mice. Neuroscience 140(2):607-622. crossref |
||||
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
